(Q44553035)

4 December 2017

title

Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model (English)

1 reference

4 December 2017

Roy Dekel

1

1 reference

4 December 2017

Isabel Zvibel

2

1 reference

4 December 2017

Shlomo Brill

3

1 reference

4 December 2017

Eli Brazovsky

4

1 reference

4 December 2017

Zamir Halpern

5

1 reference

4 December 2017

Ran Oren

6

1 reference

4 December 2017

publication date

1 August 2003

1 reference

Digestive Diseases and Sciences

4 December 2017

published in

1 reference

4 December 2017

volume

48

1 reference

4 December 2017

issue

8

1 reference

4 December 2017

page(s)

1642-1647

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1024792529601

4 December 2017

exact match

0 references

cites work

Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats

1 reference

12 December 2020

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

12 December 2020

In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats

1 reference

12 December 2020

Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor

1 reference

12 December 2020

History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells

1 reference

12 December 2020

Gliotoxin and related epipolythiodioxopiperazines

1 reference

12 December 2020

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats

1 reference

12 December 2020

Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins.

1 reference

12 December 2020

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

12 December 2020

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

12 December 2020

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

12 December 2020

A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin

1 reference

12 December 2020

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

1 reference

12 December 2020

NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis

1 reference

12 December 2020

Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers

1 reference

12 December 2020

Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB

1 reference

12 December 2020

Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis.

1 reference

12 December 2020

Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells

1 reference

12 December 2020

CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells

1 reference

12 December 2020

NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1024792529601

1 reference

Dimensions Publication ID

4 December 2017

1004954307

0 references

1 reference